HRMY — Harmony Biosciences Holdings, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-08-19.
Performance
Technicals
Others in Healthcare
Measured signals that fired on HRMY
| date | signal | measured base rate |
|---|---|---|
| 2026-08-04 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-08-04 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-04 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-05-07 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-04-13 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-04-01 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-05-01 | Budur Kumar CHIEF MEDICAL OFFICER | Shares withheld for tax | 8.9K | 31.83 | 282.7K |
| 2026-05-01 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise | 18.8K | 0.00 | 0 |
| 2026-04-07 | Zaeske Adam H. CHIEF COMMERCIAL OFFICER | Shares withheld for tax | 3.2K | 27.62 | 87.6K |
| 2026-04-07 | Zaeske Adam H. CHIEF COMMERCIAL OFFICER | Option exercise | 7.5K | 0.00 | 0 |
| 2026-01-26 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Open-market sale 10b5-1 plan | 3.7K | 37.15 | 139.2K |
| 2026-01-25 | Dayno Jeffrey M. PRESIDENT, CEO | Shares withheld for tax | 5.7K | 36.82 | 208.2K |
| 2026-01-25 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Shares withheld for tax | 2.6K | 36.82 | 94.0K |
| 2026-01-25 | Budur Kumar CHIEF MEDICAL OFFICER | Shares withheld for tax | 1.4K | 36.82 | 50.5K |
| 2026-01-25 | Serafin Andrew CHIEF STRATEGY OFFICER | Shares withheld for tax | 1.1K | 36.82 | 41.5K |
| 2026-01-25 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise | 4.7K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 198.0M | 7.1M |
| FMR LLC | 88.4M | 3.2M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 76.0M | 2.7M |
| AMERICAN CENTURY COMPANIES INC | 59.0M | 2.1M |
| VANGUARD CAPITAL MANAGEMENT LLC | 58.9M | 2.1M |
| DIMENSIONAL FUND ADVISORS LP | 58.2M | 2.1M |
| STATE STREET CORP | 50.0M | 1.8M |
| ARMISTICE CAPITAL, LLC | 45.5M | 1.6M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 38.7M | 1.4M |
| GEODE CAPITAL MANAGEMENT, LLC | 37.1M | 1.3M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
Ask the AI about HRMY
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →